Sensata Technologies has completed the sale of its valves business to Pacific Industrial Co.
Lincoln International (“Lincoln”), a leading global mid-market investment bank, is pleased to announce that Sensata Technologies (NYSE:ST; “Sensata”), a leading industrial technology company, has completed the sale of its valves business (the “Business”) to Pacific Industrial Co., Ltd. (TSE:7250; “Pacific”) for a total enterprise value of approximately $175 million.
The valves business manufactures mechanical valves for pressure applications used in tires and fluid control and assembles tire hardware aftermarket products. The Business designs, tests, qualifies and manufactures engineered valves which are “spec’d in” to platforms for automotive, aerospace, HVAC/R and heavy-duty vehicle customer applications. With two manufacturing plants in the U.S. and Europe, the Business is well capitalized with a high degree of automation and precision machining capabilities to serve its customers globally.
Pacific is an industrial valves manufacturer based in Ogaki, Japan, with manufacturing and sales operations in the U.S., Taiwan, South Korea, Thailand, China and Belgium. The Pacific brand has been established as a leader in quality and technology in overseas markets, particularly in Asia, and this move reinforces Pacific’s strategy to grow its presence in Europe and the Americas.
Lincoln acted as the exclusive investment banking advisor to Sensata. A dedicated Lincoln deal team in the U.S., France and Japan worked seamlessly together on this complex, cross-border transaction, structured as a corporate divestiture of both U.S. and French divisions. Moreover, Lincoln’s long-term track record in flow control and domain expertise in the automotive and truck and industrials sectors provided informed strategic advice to Sensata.
Meet our Senior Team
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical